193 related articles for article (PubMed ID: 12562869)
1. Circulating oxidized LDL forms complexes with beta2-glycoprotein I: implication as an atherogenic autoantigen.
Kobayashi K; Kishi M; Atsumi T; Bertolaccini ML; Makino H; Sakairi N; Yamamoto I; Yasuda T; Khamashta MA; Hughes GR; Koike T; Voelker DR; Matsuura E
J Lipid Res; 2003 Apr; 44(4):716-26. PubMed ID: 12562869
[TBL] [Abstract][Full Text] [Related]
2. Atherogenic autoantigen: oxidized LDL complexes with beta2-glycoprotein I.
Matsuura E; Kobayashia K; Koikeb T; Shoenfeld Y; Khamashta MA; Hughes GR
Immunobiology; 2003; 207(1):17-22. PubMed ID: 12638898
[TBL] [Abstract][Full Text] [Related]
3. Oxidized low-density lipoprotein as a risk factor of thrombosis in antiphospholipid syndrome.
Matsuura E; Kobayashi K; Koike T; Shoenfeld Y; Khamashta MA; Hughes GR
Lupus; 2003; 12(7):550-4. PubMed ID: 12892397
[TBL] [Abstract][Full Text] [Related]
4. Oxidized low-density lipoprotein/beta2-glycoprotein I complexes and autoantibodies to oxLig-1/beta2-glycoprotein I in patients with systemic lupus erythematosus and antiphospholipid syndrome.
Lopez D; Garcia-Valladares I; Palafox-Sanchez CA; De La Torre IG; Kobayashi K; Matsuura E; Lopez LR
Am J Clin Pathol; 2004 Mar; 121(3):426-36. PubMed ID: 15023048
[TBL] [Abstract][Full Text] [Related]
5. Autoantibody-mediated atherosclerosis.
Matsuura E; Kobayashi K; Koike T; Shoenfeld Y
Autoimmun Rev; 2002 Dec; 1(6):348-53. PubMed ID: 12848990
[TBL] [Abstract][Full Text] [Related]
6. Recombinant domain V of β2-glycoprotein I inhibits the formation of atherogenic oxLDL/β2-glycoprotein I complexes.
Li J; Chi Y; Liu S; Wang L; Wang R; Han X; Matsuura E; Liu Q
J Clin Immunol; 2014 Aug; 34(6):669-76. PubMed ID: 24970589
[TBL] [Abstract][Full Text] [Related]
7. Atherogenic oxidized low-density lipoprotein/beta2-glycoprotein I (oxLDL/beta2GPI) complexes in patients with systemic lupus erythematosus and antiphospholipid syndrome.
Matsuura E; Kobayashi K; Hurley BL; Lopez LR
Lupus; 2006; 15(7):478-83. PubMed ID: 16898186
[TBL] [Abstract][Full Text] [Related]
8. IgG autoantibodies against beta2-glycoprotein I complexed with a lipid ligand derived from oxidized low-density lipoprotein are associated with arterial thrombosis in antiphospholipid syndrome.
Lopez D; Kobayashi K; Merrill JT; Matsuura E; Lopez LR
Clin Dev Immunol; 2003; 10(2-4):203-11. PubMed ID: 14768953
[TBL] [Abstract][Full Text] [Related]
9. Omega-carboxyl variants of 7-ketocholesteryl esters are ligands for beta(2)-glycoprotein I and mediate antibody-dependent uptake of oxidized LDL by macrophages.
Liu Q; Kobayashi K; Furukawa J; Inagaki J; Sakairi N; Iwado A; Yasuda T; Koike T; Voelker DR; Matsuura E
J Lipid Res; 2002 Sep; 43(9):1486-95. PubMed ID: 12235181
[TBL] [Abstract][Full Text] [Related]
10. Are oxidized LDL/beta2-glycoprotein I complexes pathogenic antigens in autoimmune-mediated atherosclerosis?
Matsuura E; Lopez LR
Clin Dev Immunol; 2004 Jun; 11(2):103-11. PubMed ID: 15330445
[TBL] [Abstract][Full Text] [Related]
11. A specific ligand for beta(2)-glycoprotein I mediates autoantibody-dependent uptake of oxidized low density lipoprotein by macrophages.
Kobayashi K; Matsuura E; Liu Q; Furukawa J; Kaihara K; Inagaki J; Atsumi T; Sakairi N; Yasuda T; Voelker DR; Koike T
J Lipid Res; 2001 May; 42(5):697-709. PubMed ID: 11352976
[TBL] [Abstract][Full Text] [Related]
12. Oxidized low-density lipoprotein and beta2-glycoprotein I in patients with systemic lupus erythematosus and increased carotid intima-media thickness: implications in autoimmune-mediated atherosclerosis.
Lopez LR; Salazar-Paramo M; Palafox-Sanchez C; Hurley BL; Matsuura E; Garcia-De La Torre I
Lupus; 2006; 15(2):80-6. PubMed ID: 16539278
[TBL] [Abstract][Full Text] [Related]
13. OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement.
Lopez LR; Simpson DF; Hurley BL; Matsuura E
Ann N Y Acad Sci; 2005 Jun; 1051():313-22. PubMed ID: 16126973
[TBL] [Abstract][Full Text] [Related]
14. Antiphospholipid antibodies and atherosclerosis.
Matsuura E; Kobayashi K; Yasuda T; Koike T
Lupus; 1998; 7 Suppl 2():S135-9. PubMed ID: 9814691
[TBL] [Abstract][Full Text] [Related]
15. Intracellular trafficking of beta2-glycoprotein I complexes with lipid vesicles in macrophages: implications on the development of antiphospholipid syndrome.
Kajiwara T; Yasuda T; Matsuura E
J Autoimmun; 2007; 29(2-3):164-73. PubMed ID: 17826950
[TBL] [Abstract][Full Text] [Related]
16. Atherogenic antiphospholipid antibodies in antiphospholipid syndrome.
Kobayashi K; Lopez LR; Matsuura E
Ann N Y Acad Sci; 2007 Jun; 1108():489-96. PubMed ID: 17894014
[TBL] [Abstract][Full Text] [Related]
17. Antiphospholipid antibodies in arterial thrombosis.
Koike T
Ann Med; 2000 Dec; 32 Suppl 1():27-31. PubMed ID: 11209978
[TBL] [Abstract][Full Text] [Related]
18. Anti-beta 2-glycoprotein I autoantibodies and atherosclerosis.
Matsuura E; Kobayashi K; Kasahara J; Yasuda T; Makino H; Koike T; Shoenfeld Y
Int Rev Immunol; 2002; 21(1):51-66. PubMed ID: 12187845
[TBL] [Abstract][Full Text] [Related]
19. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
[TBL] [Abstract][Full Text] [Related]
20. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
